- Clearmind Medicine (NASDAQ:CMND) disclosed in an SEC filing on Monday after the bell a prospectus to offer and sell common shares, subscription rights, warrants, and units to raise $50 million.
- The prospectus is not an offer to sell the securities and is not soliciting an offer to buy the securities.
- SEC filing.
Clearmind Medicine files for $50M mixed shelf (NASDAQ:CMND)
